Join the Erectile Dysfunction group to help and get support from people like you.
Erectile Dysfunction News (Page 3)
Related terms: Erection Problems, Impotence, Sexual Dysfunction, Male, ED, Impotency
FDA Medwatch Alert: Libigrow, Libigrow XXXtreme, Blue Diamond, Blue Diamond Platinum, Mojo Nights, Mojo Nights Supreme, And Casanova: Recall - Undeclared Ingredients Sulfoaildenafil and Thioaildenafil
[Posted 12/18/2012] ISSUE: Performance Plus Marketing, Inc. Issues a Voluntary Nationwide Recall of Libigrow, Libigrow XXXtreme, Blue Diamond, Blue Diamond Platinum, Mojo Nights, Mojo Nights...
FDA Medwatch Alert: Mojo Nights and Mojo Nights for Her: Recall - Undeclared Drug Ingredient
ISSUE: Evol Nutrition Associates, Inc./Red Dawn (“Evol Nutrition”) notified the public of a nationwide recall of all lots of two dietary supplement products distributed by the company under the names ...
FDA Medwatch Alert: V Maxx RX: Recall - Undeclared Drug Ingredient
ISSUE: The Menz Club, LLC issued a nationwide recall of V Maxx Rx due to undeclared sulfoaildenafil. Sulfoaidenafil is an analog of sildenafil, an FDA approved prescription drug used to treat...
FDA Approves Stendra for Erectile Dysfunction
April 27, 2012 – The U.S. Food and Drug Administration today approved Stendra (avanafil), a new drug to treat erectile dysfunction. Erectile dysfunction is when a man has trouble getting or keeping...
FDA Medwatch Alert: X-Rock: Recall - Undeclared Drug Ingredient
ISSUE: X-Rock Industries LLC is conducting a recall of certain supplement products under the brand name of X-ROCK. Analytical tests of X-ROCK for Men conducted by FDA concluded that the products...
FDA Medwatch Alert: RegenArouse: Recall - Undeclared Drug Ingredient
ISSUE: Regeneca, Inc. notifed the public of a nationwide recall of RegenArouse, Lot Number 130100. FDA lab analysis confirmed the presence of Tadalafil, an FDA-approved drug used as treatment for...
FDA Medwatch Alert: Virility Max: Recall - Undeclared Drug Ingredient
ISSUE: FDA lab analysis for Lot 10090571 found Virility Max to contain sulfoaildenafil, an analog of sildenafil. Sildenafil is an active ingredient of an FDA approved drug for erectile dysfunction...
FDA Medwatch Alert: Via Xtreme Ultimate Sexual Enhancer Dietary Supplement For Men: Recall - Undeclared Drug Ingredient
ISSUE: FDA lab analyses found Via Xtreme Ultimate Sexual Enhancer Dietary Supplement for Men to contain sulfoaildenafil methanesulfonate, sulfosildenafil and dimethylsildenafil analogs of sildenafil....
FDA Medwatch Alert: ExtenZe Tablets: Recall
[UPDATED 05/16/2011] Additional counterfeit product lots recalled: LOT 1110075, F050899. [Posted 02/23/2011] ISSUE: FDA notified Biotab Nutraceuticals, Inc. that two lots of counterfeit product ...
FDA Medwatch Alert: Regenerect: Recall - Undeclared Drug Ingredient
ISSUE: FDA lab analysis confirmed the presence of Sulfoaildenafil, an analogue of the active ingredient of an FDA-approved drug used to treat erectile dysfunction (ED), making Regenerect an...
FDA Medwatch Alert: X-Hero and Male Enhancer: Recall - Undeclared Drug Ingredient
ISSUE: FDA lab analysis of X-Hero found the product contains sulfosildenafil, the analogue of the active ingredient of an FDA-approved drug used to treat erectile dysfunction (ED), making X-Hero an...
FDA Medwatch Alert: Best Enhancer: Recall - Undeclared Drug Ingredient
ISSUE: FDA lab analyses found that the products to contain Sulfoaildenafil, an analogue of Sildenafil, an FDA-approved drug used in the treatment of male Erectile Dysfunction (ED), making these...
FDA approves Staxyn (vardenafil HCl) orally disintegrating tablets for erectile dysfunction (ED)
Philadelphia, PA & Whitehouse Station, NJ June 18, 2010 – GlaxoSmithKline and Merck & Co., Inc. announced today the U.S. Food and Drug Administration (FDA) has approved Staxyn (vardenafil HCl), an o...
FDA Medwatch Alert: Viril-ity Power (VIP) Tablets
[Posted 05/30/2008] International Pharmaceuticals, Ltd. and FDA notified consumers and healthcare professionals that the company is recalling all supplement products sold under the brand name of...
FDA Medwatch Alert: Xiadafil VIP Tablets
[Posted 05/27/2008] FDA alerted consumers and healthcare professionals not to buy or use Xiadafil VIP Tablets sold in bottles of 8 tablets (Lot #6K029) or blister cards of 2 tablets (Lot# 6K029-SEI)....